Fujifilm’s Avigan Set For Ebola Trial
This article was originally published in PharmAsia News
Fujifilm has decided to ramp up production of a novel oral antiviral drug to prepare for potential use in Ebola patients following promising signs of activity and amid plans for an African clinical trial in the hemorrhagic disease.
You may also be interested in...
Positive clinical results pave path forward for Japanese firm’s potential istradefylline successor.
Curon thinks tenalisib can offer a differentiated and safe new therapy for hematologic cancers such as multiple forms of lymphoma. Axis and PharmaEssentia team up on TCR therapy R&D in Taiwan.
Recent moves show Chinese biotech firms are increasingly looking to go global by recruiting world-class development talent, and J&J names new APAC pharma head.